Quintiles IMS Market Access Summit

Views & Analysis

Access to new medicines is not high up the list of priorities for NHS England, but pharma must seize opportunities to promote innovation uptake.

News

GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.